Pharmacokinetic assessment of the sites of first-pass metabolism of BMS-181101, an antidepressant agent, in rats

Journal of Pharmacy and Pharmacology

Volumn 50, Issue 3, 1998, Pages 275-278

  Vachharajani, Nimish N ^a   Shyu, Wen Chyi ^a   Shah, Vinod R ^a   Barbhaiya, Rashmi H ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 FLUORO 3 [3 [4 (5 METHOXY 4 PYRIMIDINYL) 1 PIPERAZINYL]PROPYL] 1H INDOLE; ANTIDEPRESSANT AGENT;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG METABOLISM; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; LIVER METABOLISM; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT;

EID: 0031940567     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1998.tb06860.x     Document Type: Article

References (17)

1. Benet, L. Z., Wu, C.-Y., Hebert, M. F., Wacher, V. J. (1996) Intestinal drug metabolism and anti-transport processes: a potential paradigm shift in oral drug delivery. J. Contr. Rel. 39: 139-143
2. Brewster, D., Humphrey, M. J., McLeavy, M. A. (1981) The systemic bioavailability of buprenorphine by various routes of administration. J. Pharm. Pharmacol. 33: 500-506
3. Cassidy, M. K., Houston, J. B. (1980) In vivo assessment of extrahepatic conjugative metabolism of first-pass effects using the model compound phenol. J. Pharm. Pharmacol. 32: 57-59
4. Chanoine, F., Grenot, C., Heidmann, P., Junien, J. L. (1991) Pharmacokinetics of butixocort 21-propionate, budesonide, and beclomethasone dipropionate in the rat after intratracheal, intravenous and oral treatments. Drug Metab. Dispos. 19: 546-553
5. Conway, W. D., Singhvi, S. M., Gibaldi, M., Boyes, R. N. (1973) The effect of route of administration on the metabolic fate of terbutaline in the rat. Xenobiotica 3: 813-821
6. Gibaldi, M., Perrier, D. (1982) Pharmacokinetics. 2nd edn, Marcel Dekker, New York, pp 409-417
7. Ilett, K. F., Tee, L. B. G., Reeves, P. T., Minchin, R. F. (1990) Metabolism of drugs and other xenobiotics in the gut lumen and wall. Pharmacol. Ther. 46: 67-93
8. Iwamoto, K., Klaassen, C. D. (1977) First-pass effect of morphine in rats. J. Pharmacol. Exp. Ther. 200: 236-244
9. Kivistö, K. T., Bookjans, G., Fromm, M. F., Griese, E.-U., Münzel, P., Kroemer, H. K. (1996) Expression of CYP3A4, CYP3A5 and CYP3A7 in human duodenal tissue. Br. J. Clin. Pharmacol. 36: 387-389
10. Kolars, J. C., Awni, W. M., Merion, R. M., Watkins, P. B. (1991) First-pass metabolism of cyclosporin by gut. Lancet 338: 1488-1490
11. Morrison, R. A., Burkett, D. E., Arnold, M. E., D'Arienzo, C. J., Weinstein, S. H. (1991) Sites of first-pass bioactivation (hydrolysis) of orally administered zofenopril calcium in dogs. Pharm. Res. 8: 370-375
12. Riegelman, S., Collier, P. (1980) The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time. J. Pharmacokin. Biopharm. 8: 509-534
13. Shah, V. R., Srinivas, N. R., Campbell, D. A., Mantha, S., Duncan, G., Schuster, A., Whigan, D. B., Shyu, W. C. (1996) High-performance liquid chromatographic-ultraviolet assay for the simultaneous determination of BMS-181101 and its putative hydroxy metabolites in rat and monkey plasma. Biomed. Chromatogr. 10: 135-138
14. Vachharajani, N. N., Campbell, D. A., Shah, V. R., Shyu, W. C., Barbhaiya, R. H. (1994) Mass balance and absolute bioavailability of BMS-181101 in rats and monkeys. Pharm. Res. 11: S-238
15. Wacher, V. J., Wu, C-Y., Benet, L. Z. (1995) Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and p-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol. Carcinogenesis 13: 129-134
16. Watkins, P. B., Wrighton, S. A., Schuetz, E. G., Molowa, D. T., Guzelian, P. S. (1987) Identification of glucocorticoid-inducible cytochrome P-450 in the intestinal mucosa of rats and man. J. Clin. Invest. 80: 1029-1036
17. Zhong, W.-Z., Williams, M. G., Cook, K. J., VandeGiessen, T. L., Jones, B. W., Rousch, K. E. (1994) First-pass effect of cis-3,4-dichloro-N-rnethyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzamide (U-54494) in rats - a model with multiple cannulas for investigation of gastrointestinal and hepatic metabolism. Pharm. Res. 11: 1524-1529